Biomimetic computational modelling of retinal ganglion cell responses to contact lens designs with refractive and opaque non-refractive features
摘要
To computationally evaluate how single vision (SV), concentric bifocal (BF), and a contact lens with non-refractive opaque elements (AR) lens designs modulate retinal ganglion cell (RGC) activity.
MethodsWide-field retinal simulations were generated using a schematic myopic eye corrected with SV, BF, and AR designs across three stimuli (Lena image, logMAR chart, dynamic gratings), three pupil diameters, and three residual accommodative error configurations. For each configuration, retinal image montages emulating blink-induced on-eye lens movement over one second were processed through a multilayer biomimetic virtual retina model to simulate RGC spike trains, quantified using median absolute deviation (MAD) and up-crossing rate (UCR).
ResultsAcross stimuli, pupils and residual‑error configurations, SV lens design exhibited an initial transient peak in RGC firing followed by rapid decay to a steady, low-variability tonic state (MAD range: static 29.68 to 49.21, dynamic 402.74 to 409.83 kHz). The BF lens design produced increased temporal variability and burst-like activity relative to SV, that depended on pupil and residual error (MAD range: static 36.05 to 72.14, dynamic 384.37 to 413.26 kHz; UCR up to static 11.25%, dynamic 16.25%). AR lens design yielded strong and sustained phasic, burst-like activity (MAD range: static 68.64 to 129.01, dynamic 418.25 to 454 kHz; UCR up to static 20%, dynamic 18.75%), reflected in elevated MAD and UCR values.
ConclusionsIn this computational model, both BF and AR lens designs produced measurable changes in simulated RGC temporal activity relative to SV, with AR inducing greater and more configuration-independent modulation. These findings must be considered hypothesis-generating only; they are consistent with the proposition that temporal encoding of RGC response may contribute to myopia control, however, they do not establish causation. Empirical validation in prospective clinical studies is warranted before any clinical inference can be drawn.